HIV/AIDS is a serious and life-altering condition that impacts the immune system, leaving the body vulnerable to infections and diseases. Without treatment, it can lead to significant health complications, including opportunistic infections, cancer, and organ damage, ultimately resulting in death. Advances in medicine, however, have made HIV a manageable chronic condition for many individuals.

The molecular understanding of HIV has enabled the development of targeted antiretroviral therapies (ART). These treatments suppress the virus, reduce the risk of transmission, and allow individuals to lead healthier lives. By addressing the virus at the cellular level, these therapies have transformed HIV from a fatal diagnosis to a manageable condition with a near-normal life expectancy.

At iNGENū, our team of researchers and clinicians is committed to advancing the science of HIV/AIDS. Through groundbreaking research, innovative trial designs, and a focus on patients’ needs, we aim to accelerate the development of next-generation treatments, improve accessibility, and work toward a future free from HIV/AIDS.